1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
- 16 August 1990
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 170 (3), 1049-1055
- https://doi.org/10.1016/0006-291x(90)90498-c
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicityBiochemical and Biophysical Research Communications, 1987
- Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium Ion on Activities of the Enzymes in the Electron Transport System in Mouse BrainJournal of Neurochemistry, 1987
- Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ionBiochemical and Biophysical Research Communications, 1987
- Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion(MPP+): Reductive activation by NADPH cytochrome P-450 reductaseBiochemical and Biophysical Research Communications, 1986
- 1-methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodentLife Sciences, 1986
- Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+Biochemical and Biophysical Research Communications, 1986
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983